Pure Global
NCT05874557

A Study of Compound Amino Acid Capsule on Maintenance Hemodialysis Patients

Effects of Compound Amino Acid Capsule on Nutrition, Calcium and Phosphorus Metabolism in Maintenance Hemodialysis Patients
RenJi Hospital·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hemodialysis Complication
Study type
Observational
Sponsor & location
Primary sponsor
RenJi Hospital
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2023
End date
Aug 01, 2023
Enrollment
40 participants
Primary outcome

Change from Baseline Serum Albumin at 3 months,Change from Baseline Serum Albumin at 6 months,Change from Baseline Serum Albumin at 9 months

Summary

The goal of this retrospective cohort study is to investigate the effects of compound amino
 acid capsule on nutrition, calcium and phosphorus metabolism in maintenance hemodialysis(MHD)
 patients. The main questions it aims to answer are:
 
 1. Can compound amino acid capsule improve the nutritional status of MHD patients?
 
 2. Can compound amino acid capsule help to correct the calcium and phosphorus metabolism
 imbalance of MHD patients?
 
 3. Is compound amino acid capsule safe for MHD patients? We will collect the medical
 history and laboratory data of MHD patients who regularly took compound amino acid
 capsule for 9 months or did not use the same preparation in previous medical experience.
 We focus on the difference of serum albumin level between the treatment group and the
 control group within 9 months, as well as prealbumin, hemoglobin, ferritin, calcium,
 phosphorus, 1,25-OH 2-D3 and intact parathyroid hormone (iPTH).

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05874557
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05874557 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.